Global Biomaterial Market (2009-2014)
The biomaterials market is defined and explained through the introduction of biotechnology and advances in the understanding of human tissue compatibility. Developing from bio-inert materials to biodegradable materials, biomaterials are widely used in medical devices, tissue replacement, and surface coating applications. The major segments in biomaterials market are ceramics, metals, polymers, and composites. Biomaterials products are classified into orthopedic, cardiovascular, gastrointestinal, wound care, urology, plastic surgery, and others. Reconstructive surgery and orthobiologics are the dominant segments in orthopedic biomaterials market.
Biomaterials products had a market size of $25.5 billion in 2008, and the biomaterial device market size was $115.4 billion in the same year, and is expected to reach $252.7 billion in 2014. This massive revenue potential highlights the immense opportunity in the market. In the next five years, the biomaterials market is expected to grow at a CAGR of 15%.
Improved patient benefits form the most important factor stimulating market growth for biomaterials. The other market drivers are increase in aging population, rising awareness, shorter product approval time, and larger application area. However, the lack of tissue availability and proper reimbursement facilities are restraining the growth of the biomaterials market.
Improvement in fabrication technology and new product development at competitive prices will be the key to future market growth. The U.S. and Europe hold a major share of the global biomaterials market; while emerging economies such as China, India, Japan, Brazil, Russia, and Romania represent a high growth rate.
REPORT DESCRIPTION
This report uses the term biomaterials to refer to the materials used in the human body. The report segments the global biomaterial market as follows:
What makes our reports unique?
The analysts working with MarketsandMarkets come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, at MarketsandMarkets, are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.
Biomaterials products had a market size of $25.5 billion in 2008, and the biomaterial device market size was $115.4 billion in the same year, and is expected to reach $252.7 billion in 2014. This massive revenue potential highlights the immense opportunity in the market. In the next five years, the biomaterials market is expected to grow at a CAGR of 15%.
Improved patient benefits form the most important factor stimulating market growth for biomaterials. The other market drivers are increase in aging population, rising awareness, shorter product approval time, and larger application area. However, the lack of tissue availability and proper reimbursement facilities are restraining the growth of the biomaterials market.
Improvement in fabrication technology and new product development at competitive prices will be the key to future market growth. The U.S. and Europe hold a major share of the global biomaterials market; while emerging economies such as China, India, Japan, Brazil, Russia, and Romania represent a high growth rate.
REPORT DESCRIPTION
This report uses the term biomaterials to refer to the materials used in the human body. The report segments the global biomaterial market as follows:
- Biomaterials product market
Orthopaedic, cardiovascular, gastrointestinal, wound care, plastic surgery, urological and others
- Biomaterials ingredient market
Metals, polymers, ceramics, composites
- Biomaterials application market
General, surgical appliances and supplies, surgical and medical instruments, dental products, electro-medical equipment, in-vitro diagnostic products, and other applications
What makes our reports unique?
- We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.
- Each report is about 250 pages with 100+ market data tables, 40 competitive company profiles, analysis of 300 patents and a minimum of 50 micro markets, which are collectively exhaustive and mutually exclusive.
- No single report by any other publisher provides market data for all the segments viz products, services, applications, ingredients, technology, and stakeholders in a single report for all the four geographies - US, Europe, APAC, ROW.
- We provide 10% customization. Normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
- 15 pages of high level analysis including benchmarking strategies, best practices and the market’s cash cows (BCG matrix). We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.
- Comprehensive market analysis for the following sectors: Pharmaceuticals, Medical Devices, Biotechnology, Semiconductor and Electronics, Energy and Power Supplies, Food and Beverages, Chemicals, Advanced Materials, Industrial Automation, and Telecom and IT. We also analyze retailers and super-retailers, technology providers, and research and development (R&D) companies.
- Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, and stakeholders?
- What are market estimates and forecasts; which markets are doing well and which are not?
- Where are the gaps and opportunities; what is driving the market?
- Which are the key playing fields? Which are the winning edge imperatives?
- How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?
The analysts working with MarketsandMarkets come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, at MarketsandMarkets, are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.
1. INTRODUCTION
1.1. KEY TAKE-AWAYS
1.2. MARKET COVERED
1.3. REPORT DESCRIPTION
1.4. STAKEHOLDERS
2. SUMMARY
3. MARKET OVERVIEW
3.1. DRIVING FACTOR ANALYSIS OF GLOBAL BIOMATERIAL MARKET
3.1.1. SUPPLY SIDE DRIVERS
3.1.2 DEMAND SIDE DRIVERS
3.1.3. RESTRAINTS
3.1.4. OPPORTUNITIES
3.1.5. KEY COMPETITIVE POINTS
3.2. DEFINING THE GLOBAL BIOMATERIAL MARKET
3.3. DEFINING THE BIOMATERIAL DEVICE MARKET
3.4. DRIVERS
3.4.1. NEW AND IMPROVED TECHNOLOGIES
3.4.2. DEVELOPMENTS IN BIOCOMPATIBILITY SCIENCE
3.4.3. LARGE APPLICATION AREA
3.4.4 INTRODUCTION OF BIO-ABSORBABLE BIOMATERIALS
3.4.5. RISING AWARENESS
3.4.6 MEDICAL APPLICATIONS OF SYNTHETIC BIOMATERIALS
3.4.7. BIOMATERIALS HELP TREAT AGE-RELATED PROBLEMS
3.4.8. MEDICAL INSURANCE COVERAGE
3.4.9. RECENT DEVELOPMENTS IN BIOMATERIAL RESEARCH
3.4.10. INCREASING FOCUS ON PERSONAL HEALTHCARE
3.5. INHIBITORS
3.5.1. LACK OF TISSUE AVAILABILITY
3.5.2. LACK OF PROPER REIMBURSEMENT FACILITIES
3.6. OPPORTUNITIES
3.6.1. MARKET PARTICIPATION BY SMALLER COMPANIES
3.6.2. GROWING NEED FOR INTEGRATED AND COMBINED MATERIALS
3.6.3. INTELLIGENT MATERIALS WITH DYNAMIC MOLECULAR FUNCTIONS
3.6.4. EMERGING PREFERENCE FOR MINIMALLY INVASIVE SURGERY
4. BIOMATERIAL PRODUCT MARKET
4.1. ORTHOPEDIC BIOMATERIALS
4.1.1. DRIVERS
4.1.1.1. Product penetration
4.1.1.2. Increasing use of orthopedic biomaterials in spine surgery
4.1.1.3. Easy surgical procedures
4.1.2. INHIBITORS
4.1.2.1. Economic constraints
4.1.2.2. Increasing competition lessens profit margin
4.1.3. OPPORTUNITIES
4.1.3.1. Spinal treatment expected to be on the rise
4.1.4. TOP PLAYER ANALYSIS OF ORTHOPEDIC BIOMATERIAL MARKET
4.1.5. RTHOPEDIC RECONSTRUCTIVE BIOMATERIALS
4.1.5.1. Drivers
4.1.5.1.1. Wide range of products available for specific applications
4.1.5.1.2. Development of new materials with improved properties
4.1.5.2. Market inhibitors and opportunities
4.1.5.3. Top Players analysis in Orthopedic Reconstructive market
4.1.5.4. Artificial hip biomaterial market
4.1.5.4.1. Cemented prostheses biomaterial market
4.1.5.4.2. Uncemented prostheses biomaterial market
4.1.5.5. Artificial knee biomaterial market
4.1.5.5.1. Non-constraint implants
4.1.5.5.2. Semi-constraint implants
4.1.5.5.3. Constraint implants
4.1.6. TRAUMA BIOMATERIALS
4.1.6.1. Drivers
4.1.6.1.1. Sports injuries and other accidents
4.1.6.1.2. Plate and screw systems spur overall market growth
4.1.6.2. Top Players Analysis of Trauma Orthopedic Biomaterial Market
4.1.7. ORTHOBIOLOGIC BIOMATERIALS 56
4.1.7.1. Top player analysis of orthobiologics biomaterial market
4.1.7.2. DBM
4.1.7.3. Machined bone allografts
4.1.7.4. Non-proprietary allografts
4.1.7.5. Synthetic bone substitute
4.1.7.6. Bone morphogenic protein (BMP)
4.1.7.7. Platelet concentrates
4.1.8. SPORTS MEDICINE BIOMATERIALS
4.1.8.1. Market Drivers
4.1.8.2. Top player analysis of sports medicine orthopedic biomaterial market
4.1.9. BONE CEMENT
4.1.9.1. Market Drivers
4.1.9.1.1. Bone cements ease lesions and can be used with antibiotics
4.1.9.2. Inhibitors and opportunities
4.1.9.3. Top player analysis of bone cement orthopedic biomaterial market
4.1.10.SPINAL BIOMATERIALS
4.1.10.1.Drivers
4.1.10.1.1. Spinal treatment for younger patients on the rise
4.1.10.1.2. Motio- preserving devices drive growth
4.1.10.2.Inhibitors & Opportunities
4.1.10.2.1. Reimbursement challenges restrain growth
4.1.10.2.2. Technology and product development will provide scope for improvement
4.1.10.3.Top player analysis of spine orthopedic biomaterial market
4.1.10.4.Cervical Biomaterials
4.1.10.5.Lumbar Biomaterials
4.1.11.DENTAL BIOMATERIALS
4.1.11.1.Drivers
4.1.11.2.Inhibitors and opportunities
4.1.11.3.Top player analysis of dental orthopedic biomaterial market
4.1.11.4.Dental bone grafts and substitutes
4.1.11.5.Allograft
4.1.11.6.Xenograft
4.1.11.7.Synthetic dental bone graft and substitute market
4.1.11.8.Tissue regeneration
4.1.11.9.Dental membranes
4.2. CARDIOVASCULAR BIOMATERIALS
4.2.1. DRIVERS
4.2.1.1. Biomaterials enhance cardiovascular treatment
4.2.1.2. Rising number of obesity cases
4.2.1.3. Increase in thrombosis and heart failure treatments
4.2.1.4. Vascular surgery market is growing with the uses of biomaterials
4.2.2. INHIBITORS AND OPPORTUNITIES
4.2.3. TOP PLAYER ANALYSIS OF CARDIOVASCULAR BIOMATERIALS MARKET
4.2.4. CARDIAC PACEMAKERS BIOMATERIAL MARKET
4.2.4.1. Top player analysis of cardiac pacemaker cardiovascular biomaterial market
4.2.5. IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
4.2.5.1. Top player analysis of implantable cardioverter defibrillator cardiovascular biomaterial market
4.2.6. CARDIAC STENT
4.2.6.1. Top player analysis of cardiac stents biomaterial market
4.2.7. ARTIFICIAL HEART VALVES
4.2.7.1. Top player analysis of artificial heart valve cardiovascular biomaterial market
4.2.8. VASCULAR ACCESS DEVICES
4.2.8.1. Drivers & Inhibitors
4.2.8.2. Top player analysis of vascular access devices biomaterial market
4.2.9. PERIPHERAL VASCULAR GRAFTS
4.3. WOUND CARE BIOMATERIALS
4.3.1. DRIVERS
4.3.1.1. Multiple advantages over conventional wound care products
4.3.1.2. Supports healing process of the skin
4.3.1.3. Gel-based products accelerate wound healing
4.3.1.4. Prevention of bacterial colonization on sutures
4.3.1.5. Reduction in the cost of hospitalization
4.3.1.6. Eliminates frequent change of dressings
4.3.1.7. Increase in diabetes foot ulcer
4.3.2. INHIBITORS
4.3.2.1. Slow rate of product development
4.3.3. OPPORTUNITIES
4.3.3.1. Increase in penetration of negative pressure wound
4.3.3.2. Introduction of more efficient and cost effective therapies
4.3.3.3. Use of natural polymer biomaterials for stability in treatment
4.3.4. TOP PLAYER ANALYSIS OF WOUND CARE BIOMATERIAL MARKET
4.3.5. INTERNAL TISSUE SEALANT
4.3.5.1. Drivers
4.3.5.1.1. Technological advances
4.3.5.1.2. Wide range of applications and features
4.3.5.1.3. Faster healing
4.3.5.2. Top player analysis of internal tissue sealant wound care biomaterial market
4.3.5.3. Fibrin Sealants
4.3.5.4. Synthetic sealants
4.3.6. SURGICAL HEMOSTATS
4.3.6.1. Drivers
4.3.6.1.1. Surgical hemostats control bleeding
4.3.6.1.2. Reduces the need for frequent blood transfusions
4.3.6.2. Top player analysis of surgical hemostats market
4.3.6.3. Thrombin-based hemostats
4.3.6.4. Oxidized regenerated cellulose based topical hemostats
4.3.6.5. Gelatin-based hemostats
4.3.6.6. Combination hemostats
4.3.6.7. Collagen-based hemostats
4.3.6.8. Autologous-based hemostats
4.3.6.9. Polysaccharide-based hemostats
4.3.7. ADHESION BARRIERS
4.3.7.1. Drivers
4.3.7.2. Inhibitors and opportunities
4.3.7.3. Top player analysis of adhesion prevention wound care biomaterial market
4.3.7.4. Films
4.3.7.5. Gels
4.3.8. SKIN SUBSTITUTES
4.4. GASTROINTESTINAL BIOMATERIALS
4.4.1. DRIVERS
4.4.1.1. Increasing incidence of gastrointestinal diseases
4.4.1.2. FDA approval for OTC gastrointestinal drugs
4.4.2. INHIBITORS AND OPPORTUNITIES
4.4.3. TOP PLAYER ANALYSIS OF GASTROINTESTINAL BIOMATERIAL MARKET
4.5. UROLOGICAL BIOMATERIALS
4.5.1. DRIVERS
4.5.1.1. Availability of biodegradable materials for treatment
4.5.1.2. Development of scaffolds for the treatment of several disorders
4.5.2. INHIBITORS AND OPPORTUNITIES
4.5.3. TOP PLAYER ANALYSIS OF UROLOGICAL BIOMATERIAL MARKET
4.5.4. UROLOGICAL STENTS
4.5.4.1. Market Drivers
4.5.4.1.1. Stents are used in short duration treatment
4.5.4.1.2. Broad indications and growing population
4.5.4.2. Inhibitors and Opportunities
4.5.5. UROLOGICAL CATHETERS
4.5.5.1. Drivers & Inhibitors
4.5.5.1.1. Developments in catheter design have increased applicability
4.5.5.1.2. Prolonged use of catheters may lead to cancer
4.5.5.2. Opportunities
4.5.5.2.1. Use of biomaterials in catheters eliminates certain disadvantages
4.5.5.2.2. Biocompatibility of chemicals can be improved in catheters
4.5.5.3. Dialysis catheter
4.5.5.3.1. Top player analysis of dialysis catheter market
4.5.5.3.2. Hemodialysis catheter
4.5.5.3.3. Peritonial catheter
4.5.5.4. Urinary catheter
4.5.5.4.1. Indwelling catheter
4.5.5.4.2. External catheter
4.5.5.4.3. Intermittent catheter
4.6. PLASTIC SURGERY BIOMATERIALS
4.6.1. DRIVERS
4.6.1.1. Baby boomers to boost market growth
4.6.1.2. More surgeons are moving towards plastic surgery market from reconstructive procedures
4.6.1.3. Cultural factors boost the market growth
4.6.2. INHIBITORS & OPPORTUNITIES
4.6.2.1. Difficulties in treating craniofacial trauma
4.6.2.2. Male population untapped for facial surgeries
4.6.3. TOP PLAYER ANALYSIS OF PLASTIC SURGERY BIOMATERIAL MARKET
4.6.4. REAST IMPLANTS
4.6.4.1. Drivers
4.6.4.1.1. Availability of more refined procedures and wide range of choice
4.6.4.2. Inhibitors & opportunities
4.6.4.3. Top player analysis of breast implants biomaterial market
4.6.4.4. Saline-filled implants
4.6.4.5. Silicone-filled implants
4.6.5. INJECTABLE FILLERS
4.6.5.1. Drivers
4.6.5.1.1. Increase in awareness of skin care
4.6.5.1.2. Permanent results can be achieved using fillers
4.6.5.2. Inhibitors & opportunities
4.6.5.2.1. Allergy
4.6.5.3. Top player analysis of injectable fillers biomaterial market
4.6.6. FACIAL IMPLANTS
4.6.6.1. Drivers
4.6.6.1.1. Iraq war increased the demand for facial implants
4.6.6.1.2. Faster recovery and surgery times
4.6.6.2. Inhibitors and opportunities
4.6.6.3. Top player analysis of facial implants biomaterial market
4.7. OTHER BIOMATERIALS
5. BIOMATERIAL MARKET
5.1. CERAMICS
5.1.1. TOP PLAYER ANALYSIS OF CERAMICS BIOMATERIAL MARKET
5.1.2. BIOINERT CERAMICS
5.1.2.1. Drivers
5.1.2.1.1. Compatibility with high-strength applications
5.1.2.1.2. High chemical stability
5.1.2.2. Inhibitors and opportunities
5.1.2.3. Alumina
5.1.2.4. Zirconia ceramic
5.1.2.5. Other bioinert ceramics market
5.1.3. BIOACTIVE CERAMICS
5.1.3.1. Drivers
5.1.3.1.1. Ceramics aid bone formation
5.1.3.2. Inhibitors and Opportunities
5.1.3.3. Bioglass
5.1.3.4. Other bioactive ceramics market
5.1.4. BIODEGRADABLE CERAMICS
5.1.4.1. Hydroxyapetite
5.1.4.2. Others biodegradable biomaterial market
5.2. BIOMATERIAL METALS
5.2.1. DRIVERS
5.2.1.1. Balancing act of metallic biomaterials
5.2.1.2. Improved properties of metallic biomaterials
5.2.2. INHIBITORS
5.2.2.1. Corrosion may occur in the implant
5.2.3. OPPORTUNITIES
5.2.3.1. Improvement in corrosion resistance
5.2.3.2. Introduction of new alloys
5.2.4. TOP PLAYER ANALYSIS OF METALLIC BIOMATERIAL MARKET
5.2.5. PURE FORM METALS
5.2.5.1. Titanium
5.2.5.2. Gold
5.2.5.3. Silver
5.2.5.4. Platinum
5.2.6. ALLOYS
5.2.6.1. Drivers
5.2.6.1.1. Can be sterilized easily
5.2.6.2. Inhibitors and opportunities
5.2.6.3. Top player analysis of alloy biomaterial market
5.2.6.4. High Carbon Cobalt Chromium Alloy
5.3. POLYMERS
5.3.1. DRIVERS
5.3.1.1. Biodegradable naturally
5.3.1.2. Compatibility in imaging1
5.3.2. INHIBITORS AND OPPORTUNITIES
5.3.3. TOP PLAYER ANALYSIS OF POLYMER BIOMATERIAL MARKET
5.3.4. NATURAL POLYMERS
5.3.4.1. Drivers
5.3.4.1.1. Safe to use
5.3.4.1.2. They work at a molecular level
5.3.4.2. Inhibitors and opportunities
5.3.4.3. Collagen-based biomaterials
5.3.4.3.1. Drivers
5.3.4.3.1.1. Role in tissue regeneration and cellular development
5.3.4.3.1.2. Antigenic properties
5.3.4.3.1.3. Biodegradibility
5.3.4.4. Chitosan
5.3.4.5. Alginate
5.3.4.6. Others natural polymers
5.3.5. SYNTHETIC POLYMERRIC BIOMATERIALS
5.3.5.1. Hyaluronic acid (HA)
5.3.5.2. PLA/PGA (poly lactic acid/Poly lactic-co glycolic acid)
5.3.5.3. PTFE (polytetrafluoroethylene)
5.3.5.4. Other synthetic polymers
6. APPLICATION MARKET
6.1. GENERAL SURGERY
6.1.1. DRIVERS
6.1.1.1. Synthetic biomaterials make suturing easier
6.1.1.2. Biomaterials meet the stringent requirements of surgeons
6.1.1.3. Biomaterials are used as adhesion prevention materials
6.1.2. INHIBITORS AND OPPORTUNITIES
6.2. SURGICAL APPLIANCES AND SUPPLIES
6.2.1. DRIVERS
6.2.1.1. Advanced materials for surgical appliances
6.2.1.2. Advances in orthopedic and prosthetic applications
6.2.1.3. Increased healthcare spending in developed countries
6.2.1.4. Tissue engineering doesn’t have any side effects
6.2.1.5. Biomaterials accelerate natural phenomena
6.2.2. MARKET INHIBITORS
6.2.2.1. Reduced availability of outside capital
6.2.2.2. Slow approval process
6.2.3. OPPORTUNITIES
6.2.3.1. Increase in export opportunities
6.2.3.2. Future development of artificial organs
6.2.3.3. Treatment of sleep disorder
6.3. DRUG DELIVERY APPLICATIONS
6.3.1. DRIVERS
6.3.1.1. Enabling properties of biomaterials
6.3.1.2. Most biomaterials are bio-absorbable
6.3.1.3. Development of quick and effective methods
6.3.2. INHIBITORS & OPPORTUNITIES
6.3.2.1. Adverse side effects from certain biomaterials inhibits growth
6.3.2.2. Nanobiomaterials for controlled drug delivery
6.4. DENTAL PRODUCTS
6.4.1. DRIVERS
6.4.1.1. Biomaterials have wide range of dental applications
6.4.1.2. Risk of dental disease is set to increase
6.4.1.3. Improvement in polymers for dental applications
6.4.2. INHIBITORS AND OPPORTUNITIES
6.5. SURGICAL AND MEDICAL INSTRUMENTS
6.5.1. DRIVERS
6.5.1.1. Innovations in surgical instruments
6.5.1.2. Availability of cheap surgical instruments
6.5.2. INHIBITORS AND OPPORTUNITIES
6.6. ELECTRO-MEDICAL EQUIPMENT APPLICATION
6.6.1. DRIVERS
6.6.1.1. Significant increase in patient-base
6.6.1.2. Demand for efficient procedures and economies of scale
6.6.2. INHIBITORS AND OPPORTUNITIES
6.7. OTHER APPLICATIONS
7. GEOGRAPHIC ANALYSIS OF BIOMATERIAL MARKET
7.1. U.S. BIOMATERIAL MARKET
7.2. EUROPE BIOMATERIAL MARKET
8. COMPANY PROFILES
8.1. 3DM, INC.
8.2. ADVANSOURCE BIOMATERIALS CORPORATION
8.3. ALLERGAN INC.
8.4. ALLOSOURCE
8.5. ALPHATEC SPINE, INC.
8.6. AMEDICA CORPORATION
8.7. ANGIOTECH PHARMACEUTICALS, INC.
8.8. APATECH LTD.
8.9. ARTIMPLANT AB
8.10. BIOCORAL, INC.
8.11. BIOINTERACTIONS LTD.
8.12. BIORETEC LTD.
8.13. BIO SYNTECH CANADA INC.
8.14. BOSTON SCIENTIFIC CORPORATION
8.15. COLLAGEN MATRIX, INC.
8.16. CORIN GROUP PLC
8.16.1. STRATEGIES
8.17. COVALON TECHNOLOGIES
8.18. CRYOLIFE INC.
8.19. DAVOL, INC.
8.20. DEPUY ORTHOPAEDICS INC.
8.20.1. STRATEGIES & DEVELOPMENTS
8.21. ETEX CORPORATION
8.22. FORTICELL BIOSCIENCE, INC.
8.23. GENZYME BIOSURGERY
8.24. HAEMACURE CORPORATION
8.24.1. STRATEGIES & DEVELOPMENTS
8.25. INION OY
8.25.1. DEVELOPMENTS
8.26. INTEGRA LIFESCIENCES HOLDINGS CORP.
8.27. INTERNATIONAL BIOCOMPOSITES LTD.
8.28. INVIBIO LTD.
8.29. ISTO TECHNOLOGIES, INC.
8.30. KENSEY NASH CORPORATION
8.31. MEDTRONIC, INC.
8.31.1. STRATEGIES & DEVELOPMENTS
8.32. MENTOR CORPORATION
8.33. MIV THERAPEUTICS INC.
8.33.1. STRATEGIES & DEVELOPMENTS
8.34. OLYMPUS TERUMO BIOMATERIALS LTD.
8.35. ORGANOGENESIS, INC.
8.35.1. DEVELOPMENTS
8.36. ORTHOVITA
8.37. OSTEOTECH, INC.
8.38. DEVELOPMENTS
8.39. PIONEER SURGICAL TECHNOLOGY
8.39.1. STRATEGIES
8.40. POLYMER TECHNOLOGY GROUP
8.41. PROTEIN POLYMER TECHNOLOGIES INC.
8.41.1. STRATEGIES & DEVELOPMENTS
8.42. RTI BIOLOGICS, INC.
8.43. SMITH & NEPHEW PLC
8.44. SYNTHES, INC.
8.45. TEI BIOSCIENCES
8.46. TORNIER INC.
8.47. VYGON S.A
8.48. W.L. GORE & ASSOCIATES INC.
8.49. WRIGHT MEDICAL GROUP, INC.
8.50. ZIMMER HOLDING, INC.
9. PATENT ANALYSIS
APPENDIX
U.S. BIOMATERIAL PRODUCT PATENTS
EUROPE BIOMATERIAL PRODUCT PATENTS
ASIA BIOMATERIAL PRODUCT PATENTS
U.S. BIOMATERIAL PATENTS
EUROPE BIOMATERIAL PATENT
ASIA BIOMATERIAL PATENTS
1.1. KEY TAKE-AWAYS
1.2. MARKET COVERED
1.3. REPORT DESCRIPTION
1.4. STAKEHOLDERS
2. SUMMARY
3. MARKET OVERVIEW
3.1. DRIVING FACTOR ANALYSIS OF GLOBAL BIOMATERIAL MARKET
3.1.1. SUPPLY SIDE DRIVERS
3.1.2 DEMAND SIDE DRIVERS
3.1.3. RESTRAINTS
3.1.4. OPPORTUNITIES
3.1.5. KEY COMPETITIVE POINTS
3.2. DEFINING THE GLOBAL BIOMATERIAL MARKET
3.3. DEFINING THE BIOMATERIAL DEVICE MARKET
3.4. DRIVERS
3.4.1. NEW AND IMPROVED TECHNOLOGIES
3.4.2. DEVELOPMENTS IN BIOCOMPATIBILITY SCIENCE
3.4.3. LARGE APPLICATION AREA
3.4.4 INTRODUCTION OF BIO-ABSORBABLE BIOMATERIALS
3.4.5. RISING AWARENESS
3.4.6 MEDICAL APPLICATIONS OF SYNTHETIC BIOMATERIALS
3.4.7. BIOMATERIALS HELP TREAT AGE-RELATED PROBLEMS
3.4.8. MEDICAL INSURANCE COVERAGE
3.4.9. RECENT DEVELOPMENTS IN BIOMATERIAL RESEARCH
3.4.10. INCREASING FOCUS ON PERSONAL HEALTHCARE
3.5. INHIBITORS
3.5.1. LACK OF TISSUE AVAILABILITY
3.5.2. LACK OF PROPER REIMBURSEMENT FACILITIES
3.6. OPPORTUNITIES
3.6.1. MARKET PARTICIPATION BY SMALLER COMPANIES
3.6.2. GROWING NEED FOR INTEGRATED AND COMBINED MATERIALS
3.6.3. INTELLIGENT MATERIALS WITH DYNAMIC MOLECULAR FUNCTIONS
3.6.4. EMERGING PREFERENCE FOR MINIMALLY INVASIVE SURGERY
4. BIOMATERIAL PRODUCT MARKET
4.1. ORTHOPEDIC BIOMATERIALS
4.1.1. DRIVERS
4.1.1.1. Product penetration
4.1.1.2. Increasing use of orthopedic biomaterials in spine surgery
4.1.1.3. Easy surgical procedures
4.1.2. INHIBITORS
4.1.2.1. Economic constraints
4.1.2.2. Increasing competition lessens profit margin
4.1.3. OPPORTUNITIES
4.1.3.1. Spinal treatment expected to be on the rise
4.1.4. TOP PLAYER ANALYSIS OF ORTHOPEDIC BIOMATERIAL MARKET
4.1.5. RTHOPEDIC RECONSTRUCTIVE BIOMATERIALS
4.1.5.1. Drivers
4.1.5.1.1. Wide range of products available for specific applications
4.1.5.1.2. Development of new materials with improved properties
4.1.5.2. Market inhibitors and opportunities
4.1.5.3. Top Players analysis in Orthopedic Reconstructive market
4.1.5.4. Artificial hip biomaterial market
4.1.5.4.1. Cemented prostheses biomaterial market
4.1.5.4.2. Uncemented prostheses biomaterial market
4.1.5.5. Artificial knee biomaterial market
4.1.5.5.1. Non-constraint implants
4.1.5.5.2. Semi-constraint implants
4.1.5.5.3. Constraint implants
4.1.6. TRAUMA BIOMATERIALS
4.1.6.1. Drivers
4.1.6.1.1. Sports injuries and other accidents
4.1.6.1.2. Plate and screw systems spur overall market growth
4.1.6.2. Top Players Analysis of Trauma Orthopedic Biomaterial Market
4.1.7. ORTHOBIOLOGIC BIOMATERIALS 56
4.1.7.1. Top player analysis of orthobiologics biomaterial market
4.1.7.2. DBM
4.1.7.3. Machined bone allografts
4.1.7.4. Non-proprietary allografts
4.1.7.5. Synthetic bone substitute
4.1.7.6. Bone morphogenic protein (BMP)
4.1.7.7. Platelet concentrates
4.1.8. SPORTS MEDICINE BIOMATERIALS
4.1.8.1. Market Drivers
4.1.8.2. Top player analysis of sports medicine orthopedic biomaterial market
4.1.9. BONE CEMENT
4.1.9.1. Market Drivers
4.1.9.1.1. Bone cements ease lesions and can be used with antibiotics
4.1.9.2. Inhibitors and opportunities
4.1.9.3. Top player analysis of bone cement orthopedic biomaterial market
4.1.10.SPINAL BIOMATERIALS
4.1.10.1.Drivers
4.1.10.1.1. Spinal treatment for younger patients on the rise
4.1.10.1.2. Motio- preserving devices drive growth
4.1.10.2.Inhibitors & Opportunities
4.1.10.2.1. Reimbursement challenges restrain growth
4.1.10.2.2. Technology and product development will provide scope for improvement
4.1.10.3.Top player analysis of spine orthopedic biomaterial market
4.1.10.4.Cervical Biomaterials
4.1.10.5.Lumbar Biomaterials
4.1.11.DENTAL BIOMATERIALS
4.1.11.1.Drivers
4.1.11.2.Inhibitors and opportunities
4.1.11.3.Top player analysis of dental orthopedic biomaterial market
4.1.11.4.Dental bone grafts and substitutes
4.1.11.5.Allograft
4.1.11.6.Xenograft
4.1.11.7.Synthetic dental bone graft and substitute market
4.1.11.8.Tissue regeneration
4.1.11.9.Dental membranes
4.2. CARDIOVASCULAR BIOMATERIALS
4.2.1. DRIVERS
4.2.1.1. Biomaterials enhance cardiovascular treatment
4.2.1.2. Rising number of obesity cases
4.2.1.3. Increase in thrombosis and heart failure treatments
4.2.1.4. Vascular surgery market is growing with the uses of biomaterials
4.2.2. INHIBITORS AND OPPORTUNITIES
4.2.3. TOP PLAYER ANALYSIS OF CARDIOVASCULAR BIOMATERIALS MARKET
4.2.4. CARDIAC PACEMAKERS BIOMATERIAL MARKET
4.2.4.1. Top player analysis of cardiac pacemaker cardiovascular biomaterial market
4.2.5. IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
4.2.5.1. Top player analysis of implantable cardioverter defibrillator cardiovascular biomaterial market
4.2.6. CARDIAC STENT
4.2.6.1. Top player analysis of cardiac stents biomaterial market
4.2.7. ARTIFICIAL HEART VALVES
4.2.7.1. Top player analysis of artificial heart valve cardiovascular biomaterial market
4.2.8. VASCULAR ACCESS DEVICES
4.2.8.1. Drivers & Inhibitors
4.2.8.2. Top player analysis of vascular access devices biomaterial market
4.2.9. PERIPHERAL VASCULAR GRAFTS
4.3. WOUND CARE BIOMATERIALS
4.3.1. DRIVERS
4.3.1.1. Multiple advantages over conventional wound care products
4.3.1.2. Supports healing process of the skin
4.3.1.3. Gel-based products accelerate wound healing
4.3.1.4. Prevention of bacterial colonization on sutures
4.3.1.5. Reduction in the cost of hospitalization
4.3.1.6. Eliminates frequent change of dressings
4.3.1.7. Increase in diabetes foot ulcer
4.3.2. INHIBITORS
4.3.2.1. Slow rate of product development
4.3.3. OPPORTUNITIES
4.3.3.1. Increase in penetration of negative pressure wound
4.3.3.2. Introduction of more efficient and cost effective therapies
4.3.3.3. Use of natural polymer biomaterials for stability in treatment
4.3.4. TOP PLAYER ANALYSIS OF WOUND CARE BIOMATERIAL MARKET
4.3.5. INTERNAL TISSUE SEALANT
4.3.5.1. Drivers
4.3.5.1.1. Technological advances
4.3.5.1.2. Wide range of applications and features
4.3.5.1.3. Faster healing
4.3.5.2. Top player analysis of internal tissue sealant wound care biomaterial market
4.3.5.3. Fibrin Sealants
4.3.5.4. Synthetic sealants
4.3.6. SURGICAL HEMOSTATS
4.3.6.1. Drivers
4.3.6.1.1. Surgical hemostats control bleeding
4.3.6.1.2. Reduces the need for frequent blood transfusions
4.3.6.2. Top player analysis of surgical hemostats market
4.3.6.3. Thrombin-based hemostats
4.3.6.4. Oxidized regenerated cellulose based topical hemostats
4.3.6.5. Gelatin-based hemostats
4.3.6.6. Combination hemostats
4.3.6.7. Collagen-based hemostats
4.3.6.8. Autologous-based hemostats
4.3.6.9. Polysaccharide-based hemostats
4.3.7. ADHESION BARRIERS
4.3.7.1. Drivers
4.3.7.2. Inhibitors and opportunities
4.3.7.3. Top player analysis of adhesion prevention wound care biomaterial market
4.3.7.4. Films
4.3.7.5. Gels
4.3.8. SKIN SUBSTITUTES
4.4. GASTROINTESTINAL BIOMATERIALS
4.4.1. DRIVERS
4.4.1.1. Increasing incidence of gastrointestinal diseases
4.4.1.2. FDA approval for OTC gastrointestinal drugs
4.4.2. INHIBITORS AND OPPORTUNITIES
4.4.3. TOP PLAYER ANALYSIS OF GASTROINTESTINAL BIOMATERIAL MARKET
4.5. UROLOGICAL BIOMATERIALS
4.5.1. DRIVERS
4.5.1.1. Availability of biodegradable materials for treatment
4.5.1.2. Development of scaffolds for the treatment of several disorders
4.5.2. INHIBITORS AND OPPORTUNITIES
4.5.3. TOP PLAYER ANALYSIS OF UROLOGICAL BIOMATERIAL MARKET
4.5.4. UROLOGICAL STENTS
4.5.4.1. Market Drivers
4.5.4.1.1. Stents are used in short duration treatment
4.5.4.1.2. Broad indications and growing population
4.5.4.2. Inhibitors and Opportunities
4.5.5. UROLOGICAL CATHETERS
4.5.5.1. Drivers & Inhibitors
4.5.5.1.1. Developments in catheter design have increased applicability
4.5.5.1.2. Prolonged use of catheters may lead to cancer
4.5.5.2. Opportunities
4.5.5.2.1. Use of biomaterials in catheters eliminates certain disadvantages
4.5.5.2.2. Biocompatibility of chemicals can be improved in catheters
4.5.5.3. Dialysis catheter
4.5.5.3.1. Top player analysis of dialysis catheter market
4.5.5.3.2. Hemodialysis catheter
4.5.5.3.3. Peritonial catheter
4.5.5.4. Urinary catheter
4.5.5.4.1. Indwelling catheter
4.5.5.4.2. External catheter
4.5.5.4.3. Intermittent catheter
4.6. PLASTIC SURGERY BIOMATERIALS
4.6.1. DRIVERS
4.6.1.1. Baby boomers to boost market growth
4.6.1.2. More surgeons are moving towards plastic surgery market from reconstructive procedures
4.6.1.3. Cultural factors boost the market growth
4.6.2. INHIBITORS & OPPORTUNITIES
4.6.2.1. Difficulties in treating craniofacial trauma
4.6.2.2. Male population untapped for facial surgeries
4.6.3. TOP PLAYER ANALYSIS OF PLASTIC SURGERY BIOMATERIAL MARKET
4.6.4. REAST IMPLANTS
4.6.4.1. Drivers
4.6.4.1.1. Availability of more refined procedures and wide range of choice
4.6.4.2. Inhibitors & opportunities
4.6.4.3. Top player analysis of breast implants biomaterial market
4.6.4.4. Saline-filled implants
4.6.4.5. Silicone-filled implants
4.6.5. INJECTABLE FILLERS
4.6.5.1. Drivers
4.6.5.1.1. Increase in awareness of skin care
4.6.5.1.2. Permanent results can be achieved using fillers
4.6.5.2. Inhibitors & opportunities
4.6.5.2.1. Allergy
4.6.5.3. Top player analysis of injectable fillers biomaterial market
4.6.6. FACIAL IMPLANTS
4.6.6.1. Drivers
4.6.6.1.1. Iraq war increased the demand for facial implants
4.6.6.1.2. Faster recovery and surgery times
4.6.6.2. Inhibitors and opportunities
4.6.6.3. Top player analysis of facial implants biomaterial market
4.7. OTHER BIOMATERIALS
5. BIOMATERIAL MARKET
5.1. CERAMICS
5.1.1. TOP PLAYER ANALYSIS OF CERAMICS BIOMATERIAL MARKET
5.1.2. BIOINERT CERAMICS
5.1.2.1. Drivers
5.1.2.1.1. Compatibility with high-strength applications
5.1.2.1.2. High chemical stability
5.1.2.2. Inhibitors and opportunities
5.1.2.3. Alumina
5.1.2.4. Zirconia ceramic
5.1.2.5. Other bioinert ceramics market
5.1.3. BIOACTIVE CERAMICS
5.1.3.1. Drivers
5.1.3.1.1. Ceramics aid bone formation
5.1.3.2. Inhibitors and Opportunities
5.1.3.3. Bioglass
5.1.3.4. Other bioactive ceramics market
5.1.4. BIODEGRADABLE CERAMICS
5.1.4.1. Hydroxyapetite
5.1.4.2. Others biodegradable biomaterial market
5.2. BIOMATERIAL METALS
5.2.1. DRIVERS
5.2.1.1. Balancing act of metallic biomaterials
5.2.1.2. Improved properties of metallic biomaterials
5.2.2. INHIBITORS
5.2.2.1. Corrosion may occur in the implant
5.2.3. OPPORTUNITIES
5.2.3.1. Improvement in corrosion resistance
5.2.3.2. Introduction of new alloys
5.2.4. TOP PLAYER ANALYSIS OF METALLIC BIOMATERIAL MARKET
5.2.5. PURE FORM METALS
5.2.5.1. Titanium
5.2.5.2. Gold
5.2.5.3. Silver
5.2.5.4. Platinum
5.2.6. ALLOYS
5.2.6.1. Drivers
5.2.6.1.1. Can be sterilized easily
5.2.6.2. Inhibitors and opportunities
5.2.6.3. Top player analysis of alloy biomaterial market
5.2.6.4. High Carbon Cobalt Chromium Alloy
5.3. POLYMERS
5.3.1. DRIVERS
5.3.1.1. Biodegradable naturally
5.3.1.2. Compatibility in imaging1
5.3.2. INHIBITORS AND OPPORTUNITIES
5.3.3. TOP PLAYER ANALYSIS OF POLYMER BIOMATERIAL MARKET
5.3.4. NATURAL POLYMERS
5.3.4.1. Drivers
5.3.4.1.1. Safe to use
5.3.4.1.2. They work at a molecular level
5.3.4.2. Inhibitors and opportunities
5.3.4.3. Collagen-based biomaterials
5.3.4.3.1. Drivers
5.3.4.3.1.1. Role in tissue regeneration and cellular development
5.3.4.3.1.2. Antigenic properties
5.3.4.3.1.3. Biodegradibility
5.3.4.4. Chitosan
5.3.4.5. Alginate
5.3.4.6. Others natural polymers
5.3.5. SYNTHETIC POLYMERRIC BIOMATERIALS
5.3.5.1. Hyaluronic acid (HA)
5.3.5.2. PLA/PGA (poly lactic acid/Poly lactic-co glycolic acid)
5.3.5.3. PTFE (polytetrafluoroethylene)
5.3.5.4. Other synthetic polymers
6. APPLICATION MARKET
6.1. GENERAL SURGERY
6.1.1. DRIVERS
6.1.1.1. Synthetic biomaterials make suturing easier
6.1.1.2. Biomaterials meet the stringent requirements of surgeons
6.1.1.3. Biomaterials are used as adhesion prevention materials
6.1.2. INHIBITORS AND OPPORTUNITIES
6.2. SURGICAL APPLIANCES AND SUPPLIES
6.2.1. DRIVERS
6.2.1.1. Advanced materials for surgical appliances
6.2.1.2. Advances in orthopedic and prosthetic applications
6.2.1.3. Increased healthcare spending in developed countries
6.2.1.4. Tissue engineering doesn’t have any side effects
6.2.1.5. Biomaterials accelerate natural phenomena
6.2.2. MARKET INHIBITORS
6.2.2.1. Reduced availability of outside capital
6.2.2.2. Slow approval process
6.2.3. OPPORTUNITIES
6.2.3.1. Increase in export opportunities
6.2.3.2. Future development of artificial organs
6.2.3.3. Treatment of sleep disorder
6.3. DRUG DELIVERY APPLICATIONS
6.3.1. DRIVERS
6.3.1.1. Enabling properties of biomaterials
6.3.1.2. Most biomaterials are bio-absorbable
6.3.1.3. Development of quick and effective methods
6.3.2. INHIBITORS & OPPORTUNITIES
6.3.2.1. Adverse side effects from certain biomaterials inhibits growth
6.3.2.2. Nanobiomaterials for controlled drug delivery
6.4. DENTAL PRODUCTS
6.4.1. DRIVERS
6.4.1.1. Biomaterials have wide range of dental applications
6.4.1.2. Risk of dental disease is set to increase
6.4.1.3. Improvement in polymers for dental applications
6.4.2. INHIBITORS AND OPPORTUNITIES
6.5. SURGICAL AND MEDICAL INSTRUMENTS
6.5.1. DRIVERS
6.5.1.1. Innovations in surgical instruments
6.5.1.2. Availability of cheap surgical instruments
6.5.2. INHIBITORS AND OPPORTUNITIES
6.6. ELECTRO-MEDICAL EQUIPMENT APPLICATION
6.6.1. DRIVERS
6.6.1.1. Significant increase in patient-base
6.6.1.2. Demand for efficient procedures and economies of scale
6.6.2. INHIBITORS AND OPPORTUNITIES
6.7. OTHER APPLICATIONS
7. GEOGRAPHIC ANALYSIS OF BIOMATERIAL MARKET
7.1. U.S. BIOMATERIAL MARKET
7.2. EUROPE BIOMATERIAL MARKET
8. COMPANY PROFILES
8.1. 3DM, INC.
8.2. ADVANSOURCE BIOMATERIALS CORPORATION
8.3. ALLERGAN INC.
8.4. ALLOSOURCE
8.5. ALPHATEC SPINE, INC.
8.6. AMEDICA CORPORATION
8.7. ANGIOTECH PHARMACEUTICALS, INC.
8.8. APATECH LTD.
8.9. ARTIMPLANT AB
8.10. BIOCORAL, INC.
8.11. BIOINTERACTIONS LTD.
8.12. BIORETEC LTD.
8.13. BIO SYNTECH CANADA INC.
8.14. BOSTON SCIENTIFIC CORPORATION
8.15. COLLAGEN MATRIX, INC.
8.16. CORIN GROUP PLC
8.16.1. STRATEGIES
8.17. COVALON TECHNOLOGIES
8.18. CRYOLIFE INC.
8.19. DAVOL, INC.
8.20. DEPUY ORTHOPAEDICS INC.
8.20.1. STRATEGIES & DEVELOPMENTS
8.21. ETEX CORPORATION
8.22. FORTICELL BIOSCIENCE, INC.
8.23. GENZYME BIOSURGERY
8.24. HAEMACURE CORPORATION
8.24.1. STRATEGIES & DEVELOPMENTS
8.25. INION OY
8.25.1. DEVELOPMENTS
8.26. INTEGRA LIFESCIENCES HOLDINGS CORP.
8.27. INTERNATIONAL BIOCOMPOSITES LTD.
8.28. INVIBIO LTD.
8.29. ISTO TECHNOLOGIES, INC.
8.30. KENSEY NASH CORPORATION
8.31. MEDTRONIC, INC.
8.31.1. STRATEGIES & DEVELOPMENTS
8.32. MENTOR CORPORATION
8.33. MIV THERAPEUTICS INC.
8.33.1. STRATEGIES & DEVELOPMENTS
8.34. OLYMPUS TERUMO BIOMATERIALS LTD.
8.35. ORGANOGENESIS, INC.
8.35.1. DEVELOPMENTS
8.36. ORTHOVITA
8.37. OSTEOTECH, INC.
8.38. DEVELOPMENTS
8.39. PIONEER SURGICAL TECHNOLOGY
8.39.1. STRATEGIES
8.40. POLYMER TECHNOLOGY GROUP
8.41. PROTEIN POLYMER TECHNOLOGIES INC.
8.41.1. STRATEGIES & DEVELOPMENTS
8.42. RTI BIOLOGICS, INC.
8.43. SMITH & NEPHEW PLC
8.44. SYNTHES, INC.
8.45. TEI BIOSCIENCES
8.46. TORNIER INC.
8.47. VYGON S.A
8.48. W.L. GORE & ASSOCIATES INC.
8.49. WRIGHT MEDICAL GROUP, INC.
8.50. ZIMMER HOLDING, INC.
9. PATENT ANALYSIS
APPENDIX
U.S. BIOMATERIAL PRODUCT PATENTS
EUROPE BIOMATERIAL PRODUCT PATENTS
ASIA BIOMATERIAL PRODUCT PATENTS
U.S. BIOMATERIAL PATENTS
EUROPE BIOMATERIAL PATENT
ASIA BIOMATERIAL PATENTS
LIST OF TABLES
SUMMARY TABLE GLOBAL BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014($ MILLION)
TABLE 1 GLOBAL ORTHOPEDIC BIOMATERIAL DEVICE MARKET, BY TYPES2007 – 2014 ($ MILLION)
TABLE 2 GLOBAL ORTHOPEDIC BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014($ MILLION)
TABLE 3 GLOBAL ORTHOPEDIC BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 4 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 5 GLOBAL RECONSTRUCTIVE ORTHOPEDIC BIOMATERIAL DEVICE MARKET BY TYPES 2007 – 2014 ($ MILLION)
TABLE 6 GLOBAL RECONSTRUCTIVE ORTHOPEDIC BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 7 GLOBAL RECONSTRUCTIVE ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 8 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 9 GLOBAL ARTIFICIAL HIP ORTHOPEDIC BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 10 GLOBAL ARTIFICIAL HIP ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 11 GLOBAL CEMENTED PROSTHESES ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 12 GLOBAL UNCEMENTED PROSTHESES ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 13 GLOBAL ARTIFICIAL KNEE ORTHOPEDIC BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 14 GLOBAL ARTIFICIAL KNEE ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 15 GLOBAL NON-CONSTRAINT IMPLANTS ORTHOPEDIC BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLIONS)
TABLE 16 GLOBAL SEMI-CONSTRAINT ORTHOPEDIC BIOMATERIALS MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 17 GLOBAL CONSTRAINT IMPLANTS ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 18 GLOBAL TRAUMA ORTHOPEDIC BIOMATERIAL DEVICE MARKET, BY TYPES 2007 – 2014 ($ MILLION)
TABLE 19 GLOBAL TRAUMA ORTHOPEDIC BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 20 GLOBAL TRAUMA ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 21 MAJOR PLAYERS AND THEIR RESPECTIVE PRODUCT DEVELOPMENTS
TABLE 22 GLOBAL ORTHOBIOLOGICS BIOMATERIAL MARKET, BY DEVICE 2007 – 2014 ($ MILLION)
TABLE 23 GLOBAL ORTHOBIOLOGICS BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 24 GLOBAL ORTHOBIOLOGICS BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 25 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 26 GLOBAL DBM ORTHOPEDIC BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 27 GLOBAL MACHINED BONE ALLOGRAFT ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 28 GLOBAL NON-PROPRIETARY ALLOGRAFT ORTHOPEDIC MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 29 GLOBAL SYNTHETIC BONE SUBSTITUTE ORTHOPEDIC BIOMATERIALS MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 30 GLOBAL BMP ORTHOPEDIC BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 31 GLOBAL PLATELET CONCENTRATES ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 32 GLOBAL SPORTS MEDICINE ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 33 MAJOR PLAYERS AND PRODUCT DEVELOPMENTZ
TABLE 34 GLOBAL BONE CEMENT ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 35 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 36 GLOBAL SPINE ORTHOPEDIC BIOMATERIAL MARKET, BY DEVICE 2007 – 2014 ($ MILLION)
TABLE 37 GLOBAL SPINE ORTHOPEDIC BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 38 GLOBAL SPINE ORTHOPEDIC BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 39 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 40 GLOBAL CERVICAL SPINE ORTHOPEDIC BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 41 GLOBAL CERVICAL SPINE ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 42 GLOBAL LUMBAR SPINE ORTHOPEDIC BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 43 GLOBAL LUMBAR SPINE ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 44 GLOBAL DENTAL ORTHOPEDIC BIOMATERIAL DEVICE MARKET, BY TYPES 2007 – 2014 ($ MILLION)
TABLE 45 GLOBAL DENTAL ORTHOPEDIC BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 46 GLOBAL DENTAL ORTHOPEDIC BIOMATERIALS MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 47 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 48 GLOBAL DENTAL BONE GRAFT ORTHOPEDIC BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 49 GLOBAL DENTAL BONE GRAFT ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY, 2007 – 2014 ($ MILLION)
TABLE 50 GLOBAL DENTAL ALLOGRAFT ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 51 GLOBAL XENOGRAFT DENTAL BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 52 GLOBAL SYNTHETIC DENTAL BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 53 GLOBAL TISSUE REGENERATION DENTAL BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 54 GLOBAL DENTAL MEMBRANE BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 55 GLOBAL CARDIOVASCULAR BIOMATERIAL MARKET, BY TYPES 2007 – 2014 ($ MILLION)
TABLE 56 GLOBAL CARDIOVASCULAR BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 57 GLOBAL CARDIOVASCULAR BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 58 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 59 GLOBAL CARDIAC PACEMAKER CARDIOVASCULAR DEVICE MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 60 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 61 GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR CARDIOVASCULAR BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 62 MAJOR PLAYERS AND THEIR RESPECTIVE PRODUCT DEVELOPMENTS
TABLE 63 GLOBAL CARDIAC STENTS CARDIOVASCULAR BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 64 GLOBAL CARDIAC STENTS CARDIOVASCULAR BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 65 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 66 GLOBAL ARTIFICIAL HEART VALVE CARDIOVASCULAR BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 67 GLOBAL ARTIFICIAL HEART VALVE CARDIOVASCULAR BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 68 MAJOR PLAYERS AND THEIR RESPECTIVE DEVELOPMENTS
TABLE 69 GLOBAL VASCULAR ACCESS DEVICES CARDIOVASCULAR BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 70 GLOBAL VASCULAR ACCESS DEVICES CARDIOVASCULAR BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 71 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 72 GLOBAL PERIPHERAL VASCULAR GRAFTS MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 73 GLOBAL WOUND CARE BIOMATERIAL DEVICE MARKET, BY TYPES 2007 – 2014 ($ MILLION)
TABLE 74 GLOBAL WOUND CARE BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 75 GLOBAL WOUND CARE BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 76 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 77 GLOBAL INTERNAL TISSUE SEALANT WOUND CARE BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 78 GLOBAL INTERNAL TISSUE SEALANT WOUND CARE BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 79 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 80 GLOBAL FIBRIN-BASED SEALANT WOUND CARE BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 81 GLOBAL SYNTHETIC BASED SEALANT WOUND CARE BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 82 GLOBAL SURGICAL HEMOSTATS WOUND CARE BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 83 GLOBAL SURGICAL HEMOSTATS WOUND CARE BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 84 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 85 GLOBAL THROMBIN BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 86 GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 87 GLOBAL GELATIN BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 88 GLOBAL COMBINATION HEMOSTATS WOUND CARE BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 89 GLOBAL COLLAGEN BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 90 GLOBAL AUTOLOGOUS BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 91 GLOBAL POLYSACCHARIDE BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 92 GLOBAL ADHESION BARRIERS WOUND CARE MARKET, BY PRODUCTS2007 – 2014 ($ MILLION)
TABLE 93 GLOBAL ADHESION BARRIERS WOUND CARE MARKET, BY GEOGRAPHY2007 – 2014 ($ MILLION)
TABLE 94 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 95 GLOBAL FILMS WOUND CARE BIOMATERIAL MARKET, BY GEOGRAPHY2007 – 2014 ($ MILLION)
TABLE 96 GLOBAL GELS WOUND CARE BIOMATERIAL MARKET, BY GEOGRAPHY2007 – 2014 ($ MILLION)
TABLE 97 GLOBAL SKIN SUBSTITUTE WOUND CARE BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 98 GLOBAL GASTROINTESTINAL BIOMATERIAL MARKET, BY GEOGRAPHY2007 – 2014 ($ MILLION)
TABLE 99 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 100 GLOBAL UROLOGICAL BIOMATERIAL DEVICE MARKET, BY TYPES2007 – 2014 ($ MILLION)
TABLE 101 GLOBAL UROLOGICAL BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014($ MILLION)
TABLE 102 GLOBAL UROLOGICAL BIOMATERIAL MARKET, BY GEOGRAPHY2007 – 2014 ($ MILLION)
TABLE 103 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS 116
TABLE 104 GLOBAL STENTS UROLOGICAL BIOMATERIAL MARKET, BY GEOGRAPHY2007 – 2014 ($ MILLION)
TABLE 105 GLOBAL CATHETER UROLOGICAL BIOMATERIAL MARKET, BY PRODUCTS2007 – 2014 ($ MILLION)
TABLE 106 GLOBAL CATHETERS UROLOGICAL BIOMATERIAL MARKET, BY GEOGRAPHY2007 – 2014 ($ MILLION)
TABLE 107 GLOBAL DIALYSIS CATHETER UROLOGICAL BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 108 GLOBAL DIALYSIS CATHETER UROLOGICAL BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 109 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 110 GLOBAL HEMODIALYSIS CATHETER UROLOGICAL BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 111 GLOBAL PERITONIAL CATHETER UROLOGICAL BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 112 GLOBAL URINARY CATHETER UROLOGICAL BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 113 GLOBAL URINARY CATHETERS UROLOGICAL BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 114 GLOBAL INDWELLING CATHETER UROLOGICAL BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 115 GLOBAL PLASTIC SURGERY BIOMATERIAL DEVICE MARKET, BY TYPES2007 – 2014 ($ MILLION)
TABLE 116 GLOBAL PLASTIC SURGERY BIOMATERIAL MARKET, BY PRODUCTS2007 – 2014 ($ MILLION)
TABLE 117 GLOBAL PLASTIC SURGERY BIOMATERIAL MARKET, BY GEOGRAPHY2007 – 2014 ($ MILLION)
TABLE 118 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 119 GLOBAL BREAST IMPLANTS PLASTIC SURGERY BIOMATERIAL DEVICE MARKET BY TYPES 2007 – 2014 ($ MILLION)
TABLE 120 GLOBAL BREAST IMPLANTS PLASTIC SURGERY BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 121 GLOBAL BREAST IMPLANTS PLASTIC SURGERY BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 122 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 123 GLOBAL SALINE-FILLED BREAST IMPLANT BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 124 GLOBAL SILICONE-GEL BREAST IMPLANT BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 125 GLOBAL INJECTABLE FILLERS BREAST IMPLANT BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 126 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 127 GLOBAL FACIAL IMPLANTS PLASTIC SURGERY BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 128 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 129 GLOBAL BIOMATERIAL MARKET, BY TYPES 2007 – 2014 ($ MILLION)
TABLE 130 GLOBAL BIOMATERIAL CERAMICS MARKET, BY TYPES 2007 – 2014($ MILLION)
TABLE 131 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 132 TECHNOLOGICAL ADVANCEMENTS IN CERAMICS MARKET
TABLE 133 GLOBAL BIOINERT CERAMICS MARKET, BY TYPES OF BIOMATERIALS2007 – 2014 ($ MILLION)
TABLE 134 GLOBAL BIOACTIVE CERAMICS MARKET, BY TYPES 2007 – 2014 ($ MILLION)
TABLE 135 GLOBAL BIODEGRADABLE CERAMICS MARKET, BY TYPES 2007 – 2014($ MILLION)
TABLE 136 GLOBAL METALLIC BIOMATERIAL MARKET, BY TYPES 2007 – 2014($ MILLION)
TABLE 137 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 138 GLOBAL PURE FORM METALS MARKET, BY TYPES 2007 – 2014 ($ MILLION)
TABLE 139 GLOBAL ALLOY BIOMATERIAL MARKET, BY TYPES 2007 – 2014 ($ MILLION)
TABLE 140 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 141 GLOBAL POLYMER BIOMATERIALS MARKET, BY TYPES 2007 – 2014($ MILLION)
TABLE 142 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 143 GLOBAL NATURAL POLYMER BIOMATERIAL MARKET, BY TYPES 2007 – 2014 ($ MILLION)
TABLE 144 GLOBAL SYNTHETIC POLYMER BIOMATERIAL MARKET, BY TYPES OF BIOMATERIALS 2007 – 2014 ($ MILLION)
TABLE 145 APPLICATION MARKET FOR BIOMATERIALS
TABLE 146 GLOBAL BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 147 U.S. BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 148 EUROPEAN BIOMATERIAL MARKET, BY PRODUCTS,2007 – 2014 ($ MILLION)
TABLE 149 ASIAN BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 150 3DM, INC. PRODUCT PROFILE
TABLE 151 3DM, INC. STRATEGY
TABLE 152 ADVANSOURCE BIOMATERIALS CORPORATION PRODUCT PROFILE
TABLE 153 ALLERGAN INC. PRODUCT PROFILE
TABLE 154 ALLOSOURCE PRODUCT PROFILE
TABLE 155 ALLOSOURCE STRATEGY
TABLE 156 ALPHATEC SPINE, INC. PRODUCT PROFILE
TABLE 157 ALPHATEC SPINE, INC. STRATEGIES AND DEVELOPMENTS
TABLE 158 AMEDICA CORPORATION PRODUCT PROFILE
TABLE 159 AMEDICA CORPORATION DEVELOPMENTS
TABLE 160 ANGIOTECH PHARMACEUTICALS, INC. PRODUCT PROFILE
TABLE 161 NGIOTECH PHARMACEUTICALS, INC. STRATEGY
TABLE 162 APATECH LTD. PRODUCT PROFILE
TABLE 163 ARTIMPLANT AB PRODUCT PROFILE
TABLE 164 ARTIMPLANT AB STRATEGIES AND DEVELOPMENTS
TABLE 165 BIOINTERACTIONS LTD. PRODUCT PROFILE
TABLE 166 BIORETEC LTD. PRODUCT PROFILE
TABLE 167 BIO SYNTECH CANADA INC. PRODUCT PROFILE
TABLE 168 BIO SYNTECH CANADA INC. STRATEGY
TABLE 169 BOSTON SCIENTIFIC CORPORATION PRODUCT PROFILE
TABLE 170 COLLAGEN MATRIX, INC. PRODUCT PROFILE
TABLE 171 COLLAGEN MATRIX, INC. STRATEGY
TABLE 172 CORIN GROUP, PLC. PRODUCT PROFILE
TABLE 173 COVALON TECHNOLOGIES PRODUCT PROFILE
TABLE 174 COVALON STRATEGY
TABLE 175 CRYOLIFE INC, PRODUCT PROFILE
TABLE 176 CRYOLIFE INC., STRATEGY
TABLE 177 DAVOL, INC. PRODUCT PROFILE
TABLE 178 DAVOL, INC. STRATEGY
TABLE 179 DEPUY ORTHOPEDICS, INC. PRODUCT PROFILE
TABLE 180 DEPUY ORTHOPEDICS, INC. STRATEGY
TABLE 181 ETEX CORPORATION PRODUCT PROFILE
TABLE 182 ETEX CORPORATION STRATEGIES AND DEVELOPMENTS
TABLE 183 GENZYME BIOSURGERY PRODUCT PROFILE
TABLE 184 GENZYME BIOSURGERY DEVELOPMENTS
TABLE 185 INION OY PRODUCT PROFILE
TABLE 186 INTEGRA LIFE SCIENCES HOLDINGS CORP. PRODUCT PROFILE
TABLE 187 INTEGRA LIFE SCIENCES HOLDINGS CORP. STRATEGY
TABLE 188 INTERNATIONAL BIOCOMPOSITES LTD. PRODUCT PROFILE
TABLE 189 INTERNATIONAL BIOCOMPOSITES LTD. DEVELOPMENTS
TABLE 190 INVIBIO LTD. PRODUCT PROFILE
TABLE 191 INVIBIO LTD. STRATEGY
TABLE 192 ISTO TECHNOLOGIES, INC. APPLICATIONS
TABLE 192 KENSEY NASH CORPORATION PRODUCT PROFILE
TABLE 193 MEDTRONIC INC. PRODUCT PROFILE
TABLE 194 MEDTRONIC INC. STRATEGIES & DEVELOPMENTS
TABLE 195 MENTOR CORPORATION PRODUCT PROFILE
TABLE 196 MIV THERAPEUTICS INC. PRODUCT PROFILE
TABLE 197 OLYMPUS TERUMO PRODUCT PROFILE
TABLE 198 OLYMPUS TERUMO STRATEGY
TABLE 199 ORGANOGENESIS, INC. PRODUCT PROFILE
TABLE 200 ORTHOVITA PRODUCT PROFILE
TABLE 201 OSTEOTECH, INC. PRODUCT PROFILE
TABLE 202 PIONEER SURGICAL TECHNOLOGY PRODUCT PROFILE
TABLE 202 PIONEER SURGICAL TECHNOLOGY STRATEGY
TABLE 203 POLYMER TECHNOLOGY GROUP PROFILE
TABLE 204 PROTEIN POLYMER TECHNOLOGIES, INC. PRODUCT PROFILE
TABLE 205 RTI BIOLOGICS PRODUCT PROFILE
TABLE 206 RTI BIOLOGICS STRATEGIES
TABLE 207 SMITH & NEPHEW PLC PRODUCT PROFILE
TABLE 208 SMITH & NEPHEW PLC STRATEGY
TABLE 209 STRYKER CORPORATION PRODUCT PROFILE
TABLE 210 SYNTHES INC. PRODUCT PROFILE
TABLE 211 SYNTHES INC. STRATEGY
TABLE 212 TEI BIOSCIENCES PRODUCT PROFILE
TABLE 213 TORNIER INC. PRODUCT PROFILE
TABLE 214 TORNIER INC. STRATEGY
TABLE 215 VYGON S.A PRODUCT PROFILE
TABLE 216 VYGON S.A STRATEGY
TABLE 217 W.L. GORE & ASSOCIATES INC. PRODUCT PROFILE
TABLE 218 WRIGHT MEDICAL GROUP, INC. PRODUCT PROFILE
TABLE 219 WRIGHT MEDICAL GROUP, INC. DEVELOPMENTS
TABLE 220 ZIMMER HOLDINGS, INC. PRODUCT PROFILE
TABLE 221 ZIMMER HOLDINGS, INC. STRATEGY
SUMMARY TABLE GLOBAL BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014($ MILLION)
TABLE 1 GLOBAL ORTHOPEDIC BIOMATERIAL DEVICE MARKET, BY TYPES2007 – 2014 ($ MILLION)
TABLE 2 GLOBAL ORTHOPEDIC BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014($ MILLION)
TABLE 3 GLOBAL ORTHOPEDIC BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 4 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 5 GLOBAL RECONSTRUCTIVE ORTHOPEDIC BIOMATERIAL DEVICE MARKET BY TYPES 2007 – 2014 ($ MILLION)
TABLE 6 GLOBAL RECONSTRUCTIVE ORTHOPEDIC BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 7 GLOBAL RECONSTRUCTIVE ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 8 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 9 GLOBAL ARTIFICIAL HIP ORTHOPEDIC BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 10 GLOBAL ARTIFICIAL HIP ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 11 GLOBAL CEMENTED PROSTHESES ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 12 GLOBAL UNCEMENTED PROSTHESES ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 13 GLOBAL ARTIFICIAL KNEE ORTHOPEDIC BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 14 GLOBAL ARTIFICIAL KNEE ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 15 GLOBAL NON-CONSTRAINT IMPLANTS ORTHOPEDIC BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLIONS)
TABLE 16 GLOBAL SEMI-CONSTRAINT ORTHOPEDIC BIOMATERIALS MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 17 GLOBAL CONSTRAINT IMPLANTS ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 18 GLOBAL TRAUMA ORTHOPEDIC BIOMATERIAL DEVICE MARKET, BY TYPES 2007 – 2014 ($ MILLION)
TABLE 19 GLOBAL TRAUMA ORTHOPEDIC BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 20 GLOBAL TRAUMA ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 21 MAJOR PLAYERS AND THEIR RESPECTIVE PRODUCT DEVELOPMENTS
TABLE 22 GLOBAL ORTHOBIOLOGICS BIOMATERIAL MARKET, BY DEVICE 2007 – 2014 ($ MILLION)
TABLE 23 GLOBAL ORTHOBIOLOGICS BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 24 GLOBAL ORTHOBIOLOGICS BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 25 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 26 GLOBAL DBM ORTHOPEDIC BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 27 GLOBAL MACHINED BONE ALLOGRAFT ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 28 GLOBAL NON-PROPRIETARY ALLOGRAFT ORTHOPEDIC MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 29 GLOBAL SYNTHETIC BONE SUBSTITUTE ORTHOPEDIC BIOMATERIALS MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 30 GLOBAL BMP ORTHOPEDIC BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 31 GLOBAL PLATELET CONCENTRATES ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 32 GLOBAL SPORTS MEDICINE ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 33 MAJOR PLAYERS AND PRODUCT DEVELOPMENTZ
TABLE 34 GLOBAL BONE CEMENT ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 35 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 36 GLOBAL SPINE ORTHOPEDIC BIOMATERIAL MARKET, BY DEVICE 2007 – 2014 ($ MILLION)
TABLE 37 GLOBAL SPINE ORTHOPEDIC BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 38 GLOBAL SPINE ORTHOPEDIC BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 39 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 40 GLOBAL CERVICAL SPINE ORTHOPEDIC BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 41 GLOBAL CERVICAL SPINE ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 42 GLOBAL LUMBAR SPINE ORTHOPEDIC BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 43 GLOBAL LUMBAR SPINE ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 44 GLOBAL DENTAL ORTHOPEDIC BIOMATERIAL DEVICE MARKET, BY TYPES 2007 – 2014 ($ MILLION)
TABLE 45 GLOBAL DENTAL ORTHOPEDIC BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 46 GLOBAL DENTAL ORTHOPEDIC BIOMATERIALS MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 47 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 48 GLOBAL DENTAL BONE GRAFT ORTHOPEDIC BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 49 GLOBAL DENTAL BONE GRAFT ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY, 2007 – 2014 ($ MILLION)
TABLE 50 GLOBAL DENTAL ALLOGRAFT ORTHOPEDIC BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 51 GLOBAL XENOGRAFT DENTAL BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 52 GLOBAL SYNTHETIC DENTAL BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 53 GLOBAL TISSUE REGENERATION DENTAL BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 54 GLOBAL DENTAL MEMBRANE BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 55 GLOBAL CARDIOVASCULAR BIOMATERIAL MARKET, BY TYPES 2007 – 2014 ($ MILLION)
TABLE 56 GLOBAL CARDIOVASCULAR BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 57 GLOBAL CARDIOVASCULAR BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 58 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 59 GLOBAL CARDIAC PACEMAKER CARDIOVASCULAR DEVICE MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 60 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 61 GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR CARDIOVASCULAR BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 62 MAJOR PLAYERS AND THEIR RESPECTIVE PRODUCT DEVELOPMENTS
TABLE 63 GLOBAL CARDIAC STENTS CARDIOVASCULAR BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 64 GLOBAL CARDIAC STENTS CARDIOVASCULAR BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 65 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 66 GLOBAL ARTIFICIAL HEART VALVE CARDIOVASCULAR BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 67 GLOBAL ARTIFICIAL HEART VALVE CARDIOVASCULAR BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 68 MAJOR PLAYERS AND THEIR RESPECTIVE DEVELOPMENTS
TABLE 69 GLOBAL VASCULAR ACCESS DEVICES CARDIOVASCULAR BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 70 GLOBAL VASCULAR ACCESS DEVICES CARDIOVASCULAR BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 71 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 72 GLOBAL PERIPHERAL VASCULAR GRAFTS MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 73 GLOBAL WOUND CARE BIOMATERIAL DEVICE MARKET, BY TYPES 2007 – 2014 ($ MILLION)
TABLE 74 GLOBAL WOUND CARE BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 75 GLOBAL WOUND CARE BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 76 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 77 GLOBAL INTERNAL TISSUE SEALANT WOUND CARE BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 78 GLOBAL INTERNAL TISSUE SEALANT WOUND CARE BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 79 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 80 GLOBAL FIBRIN-BASED SEALANT WOUND CARE BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 81 GLOBAL SYNTHETIC BASED SEALANT WOUND CARE BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 82 GLOBAL SURGICAL HEMOSTATS WOUND CARE BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 83 GLOBAL SURGICAL HEMOSTATS WOUND CARE BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 84 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 85 GLOBAL THROMBIN BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 86 GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 87 GLOBAL GELATIN BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 88 GLOBAL COMBINATION HEMOSTATS WOUND CARE BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 89 GLOBAL COLLAGEN BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 90 GLOBAL AUTOLOGOUS BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 91 GLOBAL POLYSACCHARIDE BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 92 GLOBAL ADHESION BARRIERS WOUND CARE MARKET, BY PRODUCTS2007 – 2014 ($ MILLION)
TABLE 93 GLOBAL ADHESION BARRIERS WOUND CARE MARKET, BY GEOGRAPHY2007 – 2014 ($ MILLION)
TABLE 94 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 95 GLOBAL FILMS WOUND CARE BIOMATERIAL MARKET, BY GEOGRAPHY2007 – 2014 ($ MILLION)
TABLE 96 GLOBAL GELS WOUND CARE BIOMATERIAL MARKET, BY GEOGRAPHY2007 – 2014 ($ MILLION)
TABLE 97 GLOBAL SKIN SUBSTITUTE WOUND CARE BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 98 GLOBAL GASTROINTESTINAL BIOMATERIAL MARKET, BY GEOGRAPHY2007 – 2014 ($ MILLION)
TABLE 99 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 100 GLOBAL UROLOGICAL BIOMATERIAL DEVICE MARKET, BY TYPES2007 – 2014 ($ MILLION)
TABLE 101 GLOBAL UROLOGICAL BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014($ MILLION)
TABLE 102 GLOBAL UROLOGICAL BIOMATERIAL MARKET, BY GEOGRAPHY2007 – 2014 ($ MILLION)
TABLE 103 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS 116
TABLE 104 GLOBAL STENTS UROLOGICAL BIOMATERIAL MARKET, BY GEOGRAPHY2007 – 2014 ($ MILLION)
TABLE 105 GLOBAL CATHETER UROLOGICAL BIOMATERIAL MARKET, BY PRODUCTS2007 – 2014 ($ MILLION)
TABLE 106 GLOBAL CATHETERS UROLOGICAL BIOMATERIAL MARKET, BY GEOGRAPHY2007 – 2014 ($ MILLION)
TABLE 107 GLOBAL DIALYSIS CATHETER UROLOGICAL BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 108 GLOBAL DIALYSIS CATHETER UROLOGICAL BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 109 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 110 GLOBAL HEMODIALYSIS CATHETER UROLOGICAL BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 111 GLOBAL PERITONIAL CATHETER UROLOGICAL BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 112 GLOBAL URINARY CATHETER UROLOGICAL BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 113 GLOBAL URINARY CATHETERS UROLOGICAL BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 114 GLOBAL INDWELLING CATHETER UROLOGICAL BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 115 GLOBAL PLASTIC SURGERY BIOMATERIAL DEVICE MARKET, BY TYPES2007 – 2014 ($ MILLION)
TABLE 116 GLOBAL PLASTIC SURGERY BIOMATERIAL MARKET, BY PRODUCTS2007 – 2014 ($ MILLION)
TABLE 117 GLOBAL PLASTIC SURGERY BIOMATERIAL MARKET, BY GEOGRAPHY2007 – 2014 ($ MILLION)
TABLE 118 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 119 GLOBAL BREAST IMPLANTS PLASTIC SURGERY BIOMATERIAL DEVICE MARKET BY TYPES 2007 – 2014 ($ MILLION)
TABLE 120 GLOBAL BREAST IMPLANTS PLASTIC SURGERY BIOMATERIAL MARKET BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 121 GLOBAL BREAST IMPLANTS PLASTIC SURGERY BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 122 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 123 GLOBAL SALINE-FILLED BREAST IMPLANT BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 124 GLOBAL SILICONE-GEL BREAST IMPLANT BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 125 GLOBAL INJECTABLE FILLERS BREAST IMPLANT BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 126 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 127 GLOBAL FACIAL IMPLANTS PLASTIC SURGERY BIOMATERIAL MARKET BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 128 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 129 GLOBAL BIOMATERIAL MARKET, BY TYPES 2007 – 2014 ($ MILLION)
TABLE 130 GLOBAL BIOMATERIAL CERAMICS MARKET, BY TYPES 2007 – 2014($ MILLION)
TABLE 131 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 132 TECHNOLOGICAL ADVANCEMENTS IN CERAMICS MARKET
TABLE 133 GLOBAL BIOINERT CERAMICS MARKET, BY TYPES OF BIOMATERIALS2007 – 2014 ($ MILLION)
TABLE 134 GLOBAL BIOACTIVE CERAMICS MARKET, BY TYPES 2007 – 2014 ($ MILLION)
TABLE 135 GLOBAL BIODEGRADABLE CERAMICS MARKET, BY TYPES 2007 – 2014($ MILLION)
TABLE 136 GLOBAL METALLIC BIOMATERIAL MARKET, BY TYPES 2007 – 2014($ MILLION)
TABLE 137 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 138 GLOBAL PURE FORM METALS MARKET, BY TYPES 2007 – 2014 ($ MILLION)
TABLE 139 GLOBAL ALLOY BIOMATERIAL MARKET, BY TYPES 2007 – 2014 ($ MILLION)
TABLE 140 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 141 GLOBAL POLYMER BIOMATERIALS MARKET, BY TYPES 2007 – 2014($ MILLION)
TABLE 142 MAJOR PLAYERS AND PRODUCT DEVELOPMENTS
TABLE 143 GLOBAL NATURAL POLYMER BIOMATERIAL MARKET, BY TYPES 2007 – 2014 ($ MILLION)
TABLE 144 GLOBAL SYNTHETIC POLYMER BIOMATERIAL MARKET, BY TYPES OF BIOMATERIALS 2007 – 2014 ($ MILLION)
TABLE 145 APPLICATION MARKET FOR BIOMATERIALS
TABLE 146 GLOBAL BIOMATERIAL MARKET, BY GEOGRAPHY 2007 – 2014 ($ MILLION)
TABLE 147 U.S. BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 148 EUROPEAN BIOMATERIAL MARKET, BY PRODUCTS,2007 – 2014 ($ MILLION)
TABLE 149 ASIAN BIOMATERIAL MARKET, BY PRODUCTS 2007 – 2014 ($ MILLION)
TABLE 150 3DM, INC. PRODUCT PROFILE
TABLE 151 3DM, INC. STRATEGY
TABLE 152 ADVANSOURCE BIOMATERIALS CORPORATION PRODUCT PROFILE
TABLE 153 ALLERGAN INC. PRODUCT PROFILE
TABLE 154 ALLOSOURCE PRODUCT PROFILE
TABLE 155 ALLOSOURCE STRATEGY
TABLE 156 ALPHATEC SPINE, INC. PRODUCT PROFILE
TABLE 157 ALPHATEC SPINE, INC. STRATEGIES AND DEVELOPMENTS
TABLE 158 AMEDICA CORPORATION PRODUCT PROFILE
TABLE 159 AMEDICA CORPORATION DEVELOPMENTS
TABLE 160 ANGIOTECH PHARMACEUTICALS, INC. PRODUCT PROFILE
TABLE 161 NGIOTECH PHARMACEUTICALS, INC. STRATEGY
TABLE 162 APATECH LTD. PRODUCT PROFILE
TABLE 163 ARTIMPLANT AB PRODUCT PROFILE
TABLE 164 ARTIMPLANT AB STRATEGIES AND DEVELOPMENTS
TABLE 165 BIOINTERACTIONS LTD. PRODUCT PROFILE
TABLE 166 BIORETEC LTD. PRODUCT PROFILE
TABLE 167 BIO SYNTECH CANADA INC. PRODUCT PROFILE
TABLE 168 BIO SYNTECH CANADA INC. STRATEGY
TABLE 169 BOSTON SCIENTIFIC CORPORATION PRODUCT PROFILE
TABLE 170 COLLAGEN MATRIX, INC. PRODUCT PROFILE
TABLE 171 COLLAGEN MATRIX, INC. STRATEGY
TABLE 172 CORIN GROUP, PLC. PRODUCT PROFILE
TABLE 173 COVALON TECHNOLOGIES PRODUCT PROFILE
TABLE 174 COVALON STRATEGY
TABLE 175 CRYOLIFE INC, PRODUCT PROFILE
TABLE 176 CRYOLIFE INC., STRATEGY
TABLE 177 DAVOL, INC. PRODUCT PROFILE
TABLE 178 DAVOL, INC. STRATEGY
TABLE 179 DEPUY ORTHOPEDICS, INC. PRODUCT PROFILE
TABLE 180 DEPUY ORTHOPEDICS, INC. STRATEGY
TABLE 181 ETEX CORPORATION PRODUCT PROFILE
TABLE 182 ETEX CORPORATION STRATEGIES AND DEVELOPMENTS
TABLE 183 GENZYME BIOSURGERY PRODUCT PROFILE
TABLE 184 GENZYME BIOSURGERY DEVELOPMENTS
TABLE 185 INION OY PRODUCT PROFILE
TABLE 186 INTEGRA LIFE SCIENCES HOLDINGS CORP. PRODUCT PROFILE
TABLE 187 INTEGRA LIFE SCIENCES HOLDINGS CORP. STRATEGY
TABLE 188 INTERNATIONAL BIOCOMPOSITES LTD. PRODUCT PROFILE
TABLE 189 INTERNATIONAL BIOCOMPOSITES LTD. DEVELOPMENTS
TABLE 190 INVIBIO LTD. PRODUCT PROFILE
TABLE 191 INVIBIO LTD. STRATEGY
TABLE 192 ISTO TECHNOLOGIES, INC. APPLICATIONS
TABLE 192 KENSEY NASH CORPORATION PRODUCT PROFILE
TABLE 193 MEDTRONIC INC. PRODUCT PROFILE
TABLE 194 MEDTRONIC INC. STRATEGIES & DEVELOPMENTS
TABLE 195 MENTOR CORPORATION PRODUCT PROFILE
TABLE 196 MIV THERAPEUTICS INC. PRODUCT PROFILE
TABLE 197 OLYMPUS TERUMO PRODUCT PROFILE
TABLE 198 OLYMPUS TERUMO STRATEGY
TABLE 199 ORGANOGENESIS, INC. PRODUCT PROFILE
TABLE 200 ORTHOVITA PRODUCT PROFILE
TABLE 201 OSTEOTECH, INC. PRODUCT PROFILE
TABLE 202 PIONEER SURGICAL TECHNOLOGY PRODUCT PROFILE
TABLE 202 PIONEER SURGICAL TECHNOLOGY STRATEGY
TABLE 203 POLYMER TECHNOLOGY GROUP PROFILE
TABLE 204 PROTEIN POLYMER TECHNOLOGIES, INC. PRODUCT PROFILE
TABLE 205 RTI BIOLOGICS PRODUCT PROFILE
TABLE 206 RTI BIOLOGICS STRATEGIES
TABLE 207 SMITH & NEPHEW PLC PRODUCT PROFILE
TABLE 208 SMITH & NEPHEW PLC STRATEGY
TABLE 209 STRYKER CORPORATION PRODUCT PROFILE
TABLE 210 SYNTHES INC. PRODUCT PROFILE
TABLE 211 SYNTHES INC. STRATEGY
TABLE 212 TEI BIOSCIENCES PRODUCT PROFILE
TABLE 213 TORNIER INC. PRODUCT PROFILE
TABLE 214 TORNIER INC. STRATEGY
TABLE 215 VYGON S.A PRODUCT PROFILE
TABLE 216 VYGON S.A STRATEGY
TABLE 217 W.L. GORE & ASSOCIATES INC. PRODUCT PROFILE
TABLE 218 WRIGHT MEDICAL GROUP, INC. PRODUCT PROFILE
TABLE 219 WRIGHT MEDICAL GROUP, INC. DEVELOPMENTS
TABLE 220 ZIMMER HOLDINGS, INC. PRODUCT PROFILE
TABLE 221 ZIMMER HOLDINGS, INC. STRATEGY
LIST OF FIGURES
FIGURE 1 EVOLUTION OF BIOMATERIALS
FIGURE 2 PARENTAL STRUCTURE OF BIOMATERIALS
FIGURE 3 CHARACTERISTICS OF BIOMATERIAL SCIENCE
FIGURE 4 FACTORS AFFECTING THE BIOMATERIAL MARKET
FIGURE 5 GLOBAL BIOMATERIAL DEVICE MARKET, BY PRODUCTS (2009)
FIGURE 6 RELATIVE POTENTIAL MATRIX FOR BIOMATERIAL PRODUCTS MARKET (2014)
FIGURE 7 INCREASING DISABILITY WITH AGE
FIGURE 8 INCREASING AGING POPULATION
FIGURE 9 GEOGRAPHICAL ANALYSIS OF BIOMATERIAL MARKET (2009)
FIGURE 10 BIOMATERIALS PATENTS, BY GEOGRAPHY
FIGURE 11 PATENT TRENDS
LIST OF ACRONYMS AND ABBREVIATIONS
AAOS: American Academy of Orthopedic Surgery
AF: Atrial Fibrillation
BMP: Bone Morphogenic Protein
BTB: Bone Tendon Bone
CAGR: Compounded Annual Growth Rate
CE: Conformitй Europйene
CP: Combination Pharmacotherapy
CMF: Craniomaxillofacial
CRT: Cardiac Resynchronization Therapy
CSC: Cancellous Structure Ceramics
CT: Computed Tomography
DBM: Demineralized Bone Matrix
DES: Drug Eluting Stents
ESC: Environmental Stress Cracking
FDA: Food and Drugs Administration
HA: Hyaluronic Acid
ICD: Implantable Cardioverter Defibrillator
IDE: Investigational Device Exemption
LCP: Locking Compression Plate
MI: Myocardial Infraction
MRI: Magnetic Resonance Imaging
MIS: Minimally Invasive Surgery
MS: Multiple Sclerosis
OTC: Over the Counter
PEEK: Polyetheretherketone
PICC: Peripherally Inserted Central Catheter
PMMA: Polymethylmethacrylate
R&D: Research and Development
RF: Radio Frequency
ROW: Rest of the World
SFDA: State Food and Drugs Administration
FIGURE 1 EVOLUTION OF BIOMATERIALS
FIGURE 2 PARENTAL STRUCTURE OF BIOMATERIALS
FIGURE 3 CHARACTERISTICS OF BIOMATERIAL SCIENCE
FIGURE 4 FACTORS AFFECTING THE BIOMATERIAL MARKET
FIGURE 5 GLOBAL BIOMATERIAL DEVICE MARKET, BY PRODUCTS (2009)
FIGURE 6 RELATIVE POTENTIAL MATRIX FOR BIOMATERIAL PRODUCTS MARKET (2014)
FIGURE 7 INCREASING DISABILITY WITH AGE
FIGURE 8 INCREASING AGING POPULATION
FIGURE 9 GEOGRAPHICAL ANALYSIS OF BIOMATERIAL MARKET (2009)
FIGURE 10 BIOMATERIALS PATENTS, BY GEOGRAPHY
FIGURE 11 PATENT TRENDS
LIST OF ACRONYMS AND ABBREVIATIONS
AAOS: American Academy of Orthopedic Surgery
AF: Atrial Fibrillation
BMP: Bone Morphogenic Protein
BTB: Bone Tendon Bone
CAGR: Compounded Annual Growth Rate
CE: Conformitй Europйene
CP: Combination Pharmacotherapy
CMF: Craniomaxillofacial
CRT: Cardiac Resynchronization Therapy
CSC: Cancellous Structure Ceramics
CT: Computed Tomography
DBM: Demineralized Bone Matrix
DES: Drug Eluting Stents
ESC: Environmental Stress Cracking
FDA: Food and Drugs Administration
HA: Hyaluronic Acid
ICD: Implantable Cardioverter Defibrillator
IDE: Investigational Device Exemption
LCP: Locking Compression Plate
MI: Myocardial Infraction
MRI: Magnetic Resonance Imaging
MIS: Minimally Invasive Surgery
MS: Multiple Sclerosis
OTC: Over the Counter
PEEK: Polyetheretherketone
PICC: Peripherally Inserted Central Catheter
PMMA: Polymethylmethacrylate
R&D: Research and Development
RF: Radio Frequency
ROW: Rest of the World
SFDA: State Food and Drugs Administration
